High PCNA index in meningiomas resistant to radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 3, 1997, Pages 463-468

  Colvett, Kyle T ^c   Hsu, Dora W ^b   Su, Mei ^a   Lingood, Rita M ^a   Pardo, Francisco S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cell cycle; Immunocytochemistry; Meningioma; Proliferating cell nuclear antigen; Radiation therapy; Tumor recurrence

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MALE; MENINGIOMA; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TREATMENT FAILURE;

EID: 0030789086     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00018-7     Document Type: Article

References (39)

1. Adegbite, A. B.; Khan M. I.; Paine, K. W. E.; Tan, L. K. The recurrence of intracranial meningiomas after surgical treatment. J. Neurosurg. 58:51-56; 1983.
2. Barbaro, N. M.; Gutin, P. H.; Wilson, C. B.; Sheline, G. E.; Boldrey, E. B.; Wara, W. M. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525-528; 1987.
3. Bravo, R.; Frank, R.; Blundell, P. A.; Macdonald-Bravo, H. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 326:515-517; 1987.
4. Celis, J. E.; Celis, A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc. Natl. Acad. Sci. USA 82:3262-3266; 1985.
5. Chen, W. Y. K.; Liu, H. C. Atypical (anaplastic) meningioma: Relationship between histologic features and recurrence - A clinicopathologic study. Clin. Neuropathol. 9:74-81; 1990.
6. Chozick, B. S.; Benzil, D. L.; Stopa, E. G.; Pezzullo, J. C.; Knuckney, N. W.; Epstein M. H.; Finkelstein, S. D.; Finch, P. W. Immunohistochemical evaluation of erb B-2 and p53 protein expression in benign and atypical meningiomas. J. Neurooncol. 27:117-126; 1996.
7. Crone, K. R.; Challa, V. R.; Kute, T. E.; Moody, D. M.; Kelly, D. L., Jr. Relationship between flow cytometric features and clinical behavior of meningiomas. Neurosurgery 23:720-724; 1988.
8. de la Monte, S. M.; Flickinger, J.; Linggood, R. M. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am. J. Surg. Pathol. 10:836-843; 1986.
9. Garcia, R. L.; Coltrera, M. D.; Gown, A. M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am. J. Pathol. 134:733-739; 1989.
10. Glaholm, J.; Bloom, H. J. G.; Crow, J. H. The role of radio-therapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int. J. Radiat. Oncol. Biol. Phys. 18:755-761; 1990.
11. Goldsmith, B. J.; Wara, W. M.; Wilson, C. B.; Larson, D. A. Postoperative irradiation for subtotally resected meningiomas. J. Neurosurg. 80:195-201; 1994.
12. Gunzl, H. J.; Horn, H.; Schucke, R.; Donath, K. Prognostic value of PCNA and cytokeratins for radiation therapy of oral squamous cell carcinoma. Oral Oncol. Eur. J. Cancer 29B:141-145; 1993.
13. Hall, E. J.; Brown, J. M.; Cavanaugh, J. Radiosensitivity and the oxygen effect measured at different phases of the mitotic cycle using synchronously dividing cells of the root menstem of Vicia faba. Radiat. Res. 35:622-634; 1968.
14. Hall, P. A.; Levinson, D. A.; Woods, A. L.; Yu, C. C. W.; Kellock, D. B.; Watkins, J. A.; Barnes, D. M.; Gillet, C. E.; Camplejohn, R.; Dover, R.; Waseem, N. H.; Lane, D. P. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162:285-294; 1990.
15. Hoshino, T.; Nagashima, T.; Murovic, J. A.; Wilson, C. B.; Davis, R. L. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 58:1466-1472; 1986.
16. Hsu, D. W.; Pardo, F. S.; Efird, J. T.; Lingood, R. M.; Hedley-Whyte, E. T. Prognostic significance of proliferative indices in meningiomas. J. Neuropathol. Exp. Neurol. 53:247-255; 1994.
17. Ironside, J. W.; Battersby, R. D. E.; Lawry, J.; Loomes, R. S.; Day, C. A. DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. J. Neurosurg. 66:588-594; 1987.
18. Jaaskelanen, J.; Haltia, M.; Servo, A. Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome. Surg. Neurol. 25:233-242; 1986.
19. Jellinger, K. Histopathologic features predicting recurrence of meningiomas after (sub) total resection. Clin. Neuropathol. 7:174; 1988.
20. Jellinger, K.; Slowik, F. Histological subtypes and prognostic problems in meningiomas. J. Neurol. 208:279-298; 1975.
21. Khoshyomn, S.; Maier, H.; Morimura, T.; Litz, K.; Budka, H. Immunostaining for proliferation cell nuclear antigen: Its role in determination of proliferation in routinely processed human brain tumor specimens. Acta Neuropathol. 86:582-589; 1993.
22. Landberg, G.; Ross, G. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res. 51:4570-4574; 1991.
23. Lee, K. S.; Hoshino, T.; Rodriguez, L. A.; Bederson, J.; Davis, R. L.; Wilson, C. B. Bromodeoxyuridine labeling study of intracranial meningiomas: Proliferative potential and recurrence. Acta Neuropathol. 80:311-317; 1990.
24. Lingood, R. M.; Hsu, D. W.; Efird, J. T.; Pardo, F. S. TGFα expression in meningioma - Tumor progression and therapeutic response. J. Neurooncol. 26:45-51; 1995.
25. May, P. L.; Broome, J. C.; Lawry, J.; Buxton, R. A.; Battersby, R. D. E. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J. Neurosurg. 71:347-351; 1989.
26. Milosevic, M. F.; Frost, P. J.; Laperrierre, N. J.; Wong, C. S.; Simpson, W. J. Radiotherapy for atypical or malignant intracranial meningioma. Int. J. Radiat. Oncol. Biol. Phys. 34:817-822; 1996.
27. Miralbell, R.; Linggod, R. M.; de la Monte, S. M.; Convery, K.; Munzenrider, J. E.; Mirimanoff, R. O. The role of radio-therapy in the treatment of sub-totally resected benign meningiomas. J. Neurooncol. 13:157-164; 1992.
28. Mirimanoff, R. O.; Dosertz, D. E.; Lingood, R. M.; Ojemann, R. G.; Martuza, R. L. Meningioma: Analysis of recurrence and progression following neurosurgical resection. J. Neurosurg. 62:18-24; 1985.
29. Ogata, K.; Kurki, P.; Celis, J. E.; Nakamura, R. M.; Tan, E. M. Monoclonal antibodies to a nuclear protein (PCNA/ Cyclin) associated with DNA replication. Exp. Cell Res. 168:475-486; 1987.
30. Oka, K.; Hoshi, T.; Arai, T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation alone. Cancer 70:1545-1550; 1992.
31. Prelich, G.; Kostura, M.; Marshak, D. R.; Mathews, M. B.; Stillman, B. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 326:471-475; 1987.
32. Roggendorf, W.; Schuster, T.; Peiffer, J. Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol. 73:361-364; 1987.
33. Shibuya, M.; Hoshino, T.; Ito, S.; Wacker, M. R.; Prados, M. D.; Davis, R. L.; Wilson C. B. Meningiomas: Clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30:494-498; 1992.
34. Sinclair, W. K.; Morton, R. A. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat. Res. 29:450-474; 1966.
35. Terasima, R.; Tolamch, L. J. X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 140:490-492; 1963.
36. Xiong, Y.; Zhang, H.; Beach, D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514; 1992.
37. Younis, G. A.; Sawaya, R.; Demonte, F.; Hess, K. R.; Albrecht, S.; Bruner, J. M. Aggressive meningeal tumors: Review of a series. J. Neurosurg. 82:17-27; 1995.
38. Zimmer, C.; Gottschalk, J.; Cervos-Navarro, J.; Martin, H.; Beil, M.; Jautzke, G. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Pathol. Res. Pract. 188:951-958; 1992.
39. Zuber, M.; Tan, E. M.; Ryoji, M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol. Cell Biol. 9:57-66; 1989.